Outset Medical (OM) EBITDA Margin Growth (1y) (2020 - 2026)
Outset Medical (OM) EBITDA Margin Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.66 Bn | 197.06 Bn | 7.27 Bn | -497.00 |
| 2 | Stryker | 126.34 Bn | 122.86 Bn | 4.50 Bn | 670.00 |
| 3 | Medtronic | 119.31 Bn | 110.09 Bn | 6.41 Bn | 301.00 |
| 4 | Boston Scientific | 74.08 Bn | 73.54 Bn | 3.85 Bn | 546.00 |
| 5 | Edwards Lifesciences | 51.66 Bn | 47.40 Bn | 1.35 Bn | 264.00 |
| 6 | Dexcom | 35.13 Bn | 33.18 Bn | 830.00 Mn | 595.00 |
| 7 | GE HealthCare Technologies | 33.82 Bn | 31.71 Bn | 2.18 Bn | 89.00 |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -247.00 |
| 9 | Steris | 23.24 Bn | 22.75 Bn | 684.20 Mn | 146.00 |
| 10 | Outset Medical | 80.06 Mn | -183.13 Mn | 13.28 Mn | 413.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 413.00 |
| Mar 31, 2026 | -560.00 |
| Dec 31, 2025 | 1,313.00 |
| Sep 30, 2025 | 2,943.00 |
| Jun 30, 2025 | 5,865.00 |
| Mar 31, 2025 | 7,592.00 |
| Dec 31, 2024 | 4,826.00 |
| Sep 30, 2024 | 6,655.00 |
| Jun 30, 2024 | 831.00 |
| Mar 31, 2024 | -111.00 |
| Dec 31, 2023 | 198.00 |
| Sep 30, 2023 | -202.00 |
| Jun 30, 2023 | 5,385.00 |
| Mar 31, 2023 | -1,054.00 |
| Dec 31, 2022 | 2,050.00 |
| Sep 30, 2022 | -3,317.00 |
| Jun 30, 2022 | -5,589.00 |
| Mar 31, 2022 | 1,010.00 |
| Dec 31, 2021 | 3,838.00 |
| Sep 30, 2021 | 18,160.00 |